Who
Sean Mackay
SVP & Chief Business Officer
Company insider
Files Form 4 as: SVP & Chief Business Officer, Standard BioTools; Chief Executive Officer, IsoPlexis.
In numbers
- Trades disclosed
- 41
- Buys
- 1
- Sells
- 3
- Bought
- $30K
- Sold
- $38K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 31 Mar 2022
- Last trade
- 20 Aug 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 24 Aug 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $17K25,729 at $0.672 | filing |
| 20 Aug 2026filed 24 Aug 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $17K25,729 at $0.67 | filing |
| 20 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 20 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $26K25,729 at $1.00 | filing |
| 20 May 2026filed 22 May 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $26K25,729 at $1.00 | filing |
| 20 Mar 2026filed 8 Apr 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —272,107 at $0.00 | filing |
| 20 Mar 2026filed 8 Apr 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —612,240 at $0.00 | filing |
| 20 Mar 2026filed 8 Apr 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —612,240 at $0.00 | filing |
| 20 Mar 2026filed 8 Apr 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —272,107 at $0.00 | filing |
| 23 Feb 2026filed 24 Feb 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $23K19,661 at $1.15 | filing |
| 23 Feb 2026filed 24 Feb 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $23K19,661 at $1.15 | filing |
| 20 Nov 2025filed 24 Nov 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $25K19,661 at $1.28 | filing |
| 20 Aug 2025filed 22 Aug 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $25K19,661 at $1.27 | filing |
| 28 May 2025filed 30 May 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code F | $26K23,919 at $1.09 | filing |
| 23 May 2025filed 28 May 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Sold | $12K13,217 at $0.94 | filing |
| 22 May 2025filed 23 May 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Sold | $13K12,536 at $1.00 | filing |
| 21 May 2025filed 23 May 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Sold | $13K12,838 at $1.03 | filing |
| 21 Mar 2025filed 24 Mar 2025 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —422,500 at $0.00 | filing |
| 21 Mar 2025filed 24 Mar 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —281,667 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.